의약품 여과 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 용도, 재료 유형, 프로세스, 최종 사용자, 기능, 장비, 공정

The global Pharmaceutical Filtration Market is projected to grow from $14.7 billion in 2025 to $32.3 billion by 2035, at a compound annual growth rate (CAGR) of 8.0%. The Pharmaceutical Filtration Market is moderately consolidated, with competition led by global filtration technology providers and specialized life sciences companies focused on expanding bioprocessing capabilities. Market growth is driven by increasing biologics and vaccine production, rising adoption of single-use manufacturing systems, stringent regulatory requirements for sterile processing, and continuous innovation in membrane and depth filtration technologies. Companies are strengthening their market presence through product launches, manufacturing capacity expansions, and strategic partnerships to meet the growing demand for high-performance pharmaceutical filtration solutions. For instance, in July 2025, Merck KGaA opened a 150 million ($ 171.4 million) climate-neutral filtration manufacturing facility in Blarney, Ireland, dedicated to producing filtration devices for aseptic processing, tangential-flow filtration, and virus filtration used in biopharmaceutical manufacturing.

Based on Product, the Membrane Filters segment dominated the Pharmaceutical Filtration market in 2025 due to its extensive use in sterile filtration, biopharmaceutical manufacturing, vaccine production, and final product processing. Membrane filters provide high filtration efficiency, reliable microbial retention, and compatibility with stringent regulatory requirements, making them indispensable in pharmaceutical manufacturing. Their widespread adoption across biologics production, injectable drugs, and cell culture applications, coupled with increasing demand for high-purity pharmaceutical products, has strengthened their market position. Continuous innovations in membrane materials, improved filtration performance, and the growing adoption of single-use manufacturing technologies further support the segment's leadership across pharmaceutical, biotechnology, and contract manufacturing facilities worldwide.

Based on Technology, the Single-use Systems segment is projected to register the fastest growth during the forecast period, driven by the pharmaceutical industry's increasing shift toward flexible, contamination-free, and cost-efficient manufacturing processes. Single-use filtration systems eliminate cleaning validation requirements, reduce operational downtime, and minimize cross-contamination risks, making them highly suitable for biologics, vaccines, and personalized medicine production. Growing investments in biopharmaceutical manufacturing, expanding adoption of disposable processing technologies, and increasing demand for rapid production scalability are accelerating their deployment. Furthermore, advancements in single-use filtration components and rising regulatory emphasis on manufacturing efficiency are expected to significantly boost segment growth throughout the forecast period.

Geographical Overview

North America dominated the Pharmaceutical Filtration market in 2025, supported by its advanced pharmaceutical and biopharmaceutical manufacturing infrastructure, stringent regulatory standards, and significant investments in life sciences research. The region benefits from the strong presence of leading pharmaceutical manufacturers, biotechnology companies, and filtration technology providers, driving continuous demand for high-performance sterile filtration solutions. The United States accounts for the largest regional share owing to extensive biologics production, expanding vaccine manufacturing, increasing adoption of single-use bioprocessing technologies, and substantial research and development activities. Canada further contributes through growing investments in biopharmaceutical innovation and supportive government initiatives that strengthen pharmaceutical manufacturing capabilities.

Asia-Pacific is projected to register the fastest growth during the forecast period, driven by rapidly expanding pharmaceutical manufacturing, increasing biologics production, and rising investments in healthcare infrastructure. Countries such as China, India, Japan, and South Korea are significantly expanding their biopharmaceutical production capacities to meet growing domestic and global demand. Government support for pharmaceutical innovation, increasing contract manufacturing activities, and rising adoption of advanced filtration technologies are accelerating market growth. Additionally, growing healthcare expenditure, favorable regulatory reforms, and the expansion of vaccine and biosimilar manufacturing are expected to further strengthen the demand for pharmaceutical filtration solutions across the region.

Key Trends and Drivers

Increasing Adoption of Single-Use Filtration Technologies:

The Pharmaceutical Filtration market is witnessing a strong trend toward the adoption of single-use filtration technologies as pharmaceutical and biopharmaceutical manufacturers seek greater operational flexibility, faster production turnaround, and reduced contamination risks. Disposable filtration systems eliminate cleaning validation requirements, lower maintenance costs, and improve manufacturing efficiency, making them ideal for biologics, vaccines, and cell and gene therapies. Continuous advancements in filtration materials, membrane technologies, and integrated bioprocessing systems are further enhancing product performance. The growing shift toward flexible manufacturing facilities and personalized medicine is expected to accelerate the deployment of single-use filtration solutions across the pharmaceutical industry.

Growing Demand for Biopharmaceutical Manufacturing and Sterile Processing:

The increasing production of biologics, biosimilars, vaccines, and advanced therapeutics is a major driver of the Pharmaceutical Filtration market. Biopharmaceutical manufacturing requires highly efficient sterile filtration systems to ensure product purity, regulatory compliance, and patient safety throughout the production process. Rising investments in biopharmaceutical manufacturing facilities, expanding vaccine production capacity, and growing outsourcing to contract manufacturing organizations (CMOs) are significantly boosting demand for advanced filtration technologies. Furthermore, stringent global regulatory standards for aseptic manufacturing and continuous technological advancements in filtration systems are supporting widespread adoption and long-term market growth.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by Material Type
• 2.6 Key Market Highlights by Process
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Stage
• 2.9 Key Market Highlights by Functionality
• 2.10 Key Market Highlights by Equipment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Microfiltration
  • 4.1.2 Ultrafiltration
  • 4.1.3 Nanofiltration
  • 4.1.4 Reverse Osmosis
  • 4.1.5 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Membrane Filters
  • 4.2.2 Cartridge Filters
  • 4.2.3 Capsule Filters
  • 4.2.4 Filter Holders
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Single-use Systems
  • 4.3.2 Continuous Filtration
  • 4.3.3 Depth Filtration
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Final Product Processing
  • 4.4.2 Raw Material Filtration
  • 4.4.3 Cell Separation
  • 4.4.4 Water Purification
  • 4.4.5 Air Purification
  • 4.4.6 Others
• 4.5 Market Size & Forecast by Material Type (2020-2035)
  • 4.5.1 Polyethersulfone (PES)
  • 4.5.2 Polyvinylidene Fluoride (PVDF)
  • 4.5.3 Nylon
  • 4.5.4 Polytetrafluoroethylene (PTFE)
  • 4.5.5 Polypropylene
  • 4.5.6 Others
• 4.6 Market Size & Forecast by Process (2020-2035)
  • 4.6.1 Sterile Filtration
  • 4.6.2 Non-Sterile Filtration
  • 4.6.3 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Pharmaceutical Companies
  • 4.7.2 Biotechnology Companies
  • 4.7.3 Contract Manufacturing Organizations
  • 4.7.4 Research and Development Laboratories
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Stage (2020-2035)
  • 4.8.1 Upstream Processing
  • 4.8.2 Downstream Processing
  • 4.8.3 Others
• 4.9 Market Size & Forecast by Functionality (2020-2035)
  • 4.9.1 Clarification
  • 4.9.2 Concentration
  • 4.9.3 Purification
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Equipment (2020-2035)
  • 4.10.1 Filtration Systems
  • 4.10.2 Filter Media
  • 4.10.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Application
    • 5.2.1.5 Material Type
    • 5.2.1.6 Process
    • 5.2.1.7 End User
    • 5.2.1.8 Stage
    • 5.2.1.9 Functionality
    • 5.2.1.10 Equipment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Application
    • 5.2.2.5 Material Type
    • 5.2.2.6 Process
    • 5.2.2.7 End User
    • 5.2.2.8 Stage
    • 5.2.2.9 Functionality
    • 5.2.2.10 Equipment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Application
    • 5.2.3.5 Material Type
    • 5.2.3.6 Process
    • 5.2.3.7 End User
    • 5.2.3.8 Stage
    • 5.2.3.9 Functionality
    • 5.2.3.10 Equipment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Application
    • 5.3.1.5 Material Type
    • 5.3.1.6 Process
    • 5.3.1.7 End User
    • 5.3.1.8 Stage
    • 5.3.1.9 Functionality
    • 5.3.1.10 Equipment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Application
    • 5.3.2.5 Material Type
    • 5.3.2.6 Process
    • 5.3.2.7 End User
    • 5.3.2.8 Stage
    • 5.3.2.9 Functionality
    • 5.3.2.10 Equipment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Application
    • 5.3.3.5 Material Type
    • 5.3.3.6 Process
    • 5.3.3.7 End User
    • 5.3.3.8 Stage
    • 5.3.3.9 Functionality
    • 5.3.3.10 Equipment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Application
    • 5.4.1.5 Material Type
    • 5.4.1.6 Process
    • 5.4.1.7 End User
    • 5.4.1.8 Stage
    • 5.4.1.9 Functionality
    • 5.4.1.10 Equipment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Application
    • 5.4.2.5 Material Type
    • 5.4.2.6 Process
    • 5.4.2.7 End User
    • 5.4.2.8 Stage
    • 5.4.2.9 Functionality
    • 5.4.2.10 Equipment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Application
    • 5.4.3.5 Material Type
    • 5.4.3.6 Process
    • 5.4.3.7 End User
    • 5.4.3.8 Stage
    • 5.4.3.9 Functionality
    • 5.4.3.10 Equipment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Application
    • 5.4.4.5 Material Type
    • 5.4.4.6 Process
    • 5.4.4.7 End User
    • 5.4.4.8 Stage
    • 5.4.4.9 Functionality
    • 5.4.4.10 Equipment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Application
    • 5.4.5.5 Material Type
    • 5.4.5.6 Process
    • 5.4.5.7 End User
    • 5.4.5.8 Stage
    • 5.4.5.9 Functionality
    • 5.4.5.10 Equipment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Application
    • 5.4.6.5 Material Type
    • 5.4.6.6 Process
    • 5.4.6.7 End User
    • 5.4.6.8 Stage
    • 5.4.6.9 Functionality
    • 5.4.6.10 Equipment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Application
    • 5.4.7.5 Material Type
    • 5.4.7.6 Process
    • 5.4.7.7 End User
    • 5.4.7.8 Stage
    • 5.4.7.9 Functionality
    • 5.4.7.10 Equipment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Application
    • 5.5.1.5 Material Type
    • 5.5.1.6 Process
    • 5.5.1.7 End User
    • 5.5.1.8 Stage
    • 5.5.1.9 Functionality
    • 5.5.1.10 Equipment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Application
    • 5.5.2.5 Material Type
    • 5.5.2.6 Process
    • 5.5.2.7 End User
    • 5.5.2.8 Stage
    • 5.5.2.9 Functionality
    • 5.5.2.10 Equipment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Application
    • 5.5.3.5 Material Type
    • 5.5.3.6 Process
    • 5.5.3.7 End User
    • 5.5.3.8 Stage
    • 5.5.3.9 Functionality
    • 5.5.3.10 Equipment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Application
    • 5.5.4.5 Material Type
    • 5.5.4.6 Process
    • 5.5.4.7 End User
    • 5.5.4.8 Stage
    • 5.5.4.9 Functionality
    • 5.5.4.10 Equipment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Application
    • 5.5.5.5 Material Type
    • 5.5.5.6 Process
    • 5.5.5.7 End User
    • 5.5.5.8 Stage
    • 5.5.5.9 Functionality
    • 5.5.5.10 Equipment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Application
    • 5.5.6.5 Material Type
    • 5.5.6.6 Process
    • 5.5.6.7 End User
    • 5.5.6.8 Stage
    • 5.5.6.9 Functionality
    • 5.5.6.10 Equipment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Application
    • 5.6.1.5 Material Type
    • 5.6.1.6 Process
    • 5.6.1.7 End User
    • 5.6.1.8 Stage
    • 5.6.1.9 Functionality
    • 5.6.1.10 Equipment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Application
    • 5.6.2.5 Material Type
    • 5.6.2.6 Process
    • 5.6.2.7 End User
    • 5.6.2.8 Stage
    • 5.6.2.9 Functionality
    • 5.6.2.10 Equipment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Application
    • 5.6.3.5 Material Type
    • 5.6.3.6 Process
    • 5.6.3.7 End User
    • 5.6.3.8 Stage
    • 5.6.3.9 Functionality
    • 5.6.3.10 Equipment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Application
    • 5.6.4.5 Material Type
    • 5.6.4.6 Process
    • 5.6.4.7 End User
    • 5.6.4.8 Stage
    • 5.6.4.9 Functionality
    • 5.6.4.10 Equipment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Application
    • 5.6.5.5 Material Type
    • 5.6.5.6 Process
    • 5.6.5.7 End User
    • 5.6.5.8 Stage
    • 5.6.5.9 Functionality
    • 5.6.5.10 Equipment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Merck KGaA
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Danaher Corporation
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Sartorius AG
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Pall Corporation
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 GE Healthcare
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Thermo Fisher Scientific
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 3M Company
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Parker Hannifin Corporation
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Donaldson Company
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Eaton Corporation
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Meissner Filtration Products
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Graver Technologies
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Porvair Filtration Group
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Amazon Filters
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Membrane Solutions
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Sterlitech Corporation
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Saint-Gobain Performance Plastics
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Filtration Group Corporation
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Cole-Parmer Instrument Company
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Repligen Corporation
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us